Navigation Links
Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
Date:3/19/2009

rption and efficacy of drugs in ocular tissues through electrostatic attraction between the positive charge of the therapeutic emulsion and the eye's negatively charged mucous, cornea, and conjunctiva. Furthermore, the electrostatic attraction and colloidal properties that increase therapeutic residence time on the eye's anterior, also benefit the eye's posterior. Increased contact and penetration into the cornea and conjunctiva allows for more of the drug to diffuse to the anterior segment as well.

Compared to conventional eye drops and anionic emulsions, Novasorb formulations exhibit a four-fold higher spreading coefficient allowing for increased wettability of the eye's surface while also protecting against mechanical damage that occurs from blinking. This increase in residence time on the surface of the eye is key to achieving therapeutic drug levels when treating ocular conditions. It also means the patient will require fewer instillations, which will undoubtedly decrease side effects and increase patient compliance.

Novagali has further expanded upon its novel emulsion technology platform to also treat serious diseases of the back of the eye. Eyeject is an intra-ocular delivery platform that offers a minimally-invasive alternative to ocular implants for treating disease in the eye's posterior. This injectable emulsion provides a prolonged, controlled release of medication at the retina and choroid, yet can easily be administered in a non-surgical setting. Safe and effective, Eyeject is an organic, solvent- and preservative-free emulsion that includes only ophthalmologically biocompatible excipients. Novagali is investigating Eyeject's use in treating a number of posterior ophthalmic diseases, including macular edema and diabetic retinopathy.

Novagali's broad research portfolio includes seven compounds that utilize Novasorb or Eyeject technology to treat not only common eye conditions, but orphan diseases as we
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
2. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
3. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
4. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
5. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
6. Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence
7. Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies
8. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
9. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
10. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
11. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  Today, Americord Registry, one of the fastest growing cord ... a partner at Kirkland & Ellis LLP, as the newest ... http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled about ... Martin Smithmyer , CEO of Americord. "He brings a wealth ... assist Americord,s growth and vision." Andrew Horne ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... that does not sacrifice selectivity to achieve faster flow rates in comparison to ... pores with significant open space to allow easy liquid flow while trapping particulates ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares proposed to ... shares (including shares of unvested restricted stock). On June 29, 2015, the last trading ... Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The tender offer ...
(Date:6/30/2015)... 30, 2015  The University of California, San ... and UC San Diego Extension announced their third ... Aug.  12 – 14, 2015, at UC San ... provides an intense exposure to best practices and ... well-suited to biologists, process engineers and business executives ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2
... 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) ... of 6,700,000 shares of its common stock at a price ... is expected to close on or around Wednesday, April 13, ... the sole book-running manager in this offering and Sangamo has ...
... RICHMOND, Calif., April 7, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... to sell 6,700,000 shares of its common stock pursuant to ... Barclays Capital Inc. is the sole book-running manager in this ... day option to purchase up to 1,005,000 additional shares. ...
... The Center for Business Intelligence (CBI) announced today that ... in support of the relief efforts in Japan following a ... the fund while the organization matched employee donations. ... employees have displayed to help a nation in a desperate ...
Cached Biology Technology:Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland , ... ®   Produktlinie mit DNA-Tests verbessert ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... neue STR-Testkits der Produktlinie Investigator ® ... den Markt eingeführt. Die neuen Kits zur Erstellung genetischer ...
(Date:6/16/2015)... 2015 /CNW Telbec/ - handyem Inc. and FlowMetric ... incorporation of handyem,s HPC-150 portable flow cytometer within ... This unprecedented model of mobile laboratory platform is ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue ...
(Date:6/15/2015)... 2015 According to a new ... (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern ... by MarketsandMarkets, The Natural Language Processing Market is expected ... 18.4% for the forecast period 2015-2020. ... igures spread   through 155 P ages ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
... Southern Medical University in Guangdong, Guangzhou, China, have developed ... bacteria responsible for peptic ulcers and some forms of ... The research is published ahead of print in the ... The investigators constructed a live recombinant bacterial vaccine, expressing ...
... lung damage and adrenal hormone abnormalities not previously seen ... study published Dec. 18, 2013 in the journal ... spill heavily oiled Barataria Bay. The study was conducted ... Damage Assessment (NRDA) by a team of government, academic ...
... BELL, Pa. , Dec. 19, 2013 Security experts ... today predicted that the coming year will usher in broad-based ... unencrypted data traffic inside enterprises is vulnerable to detection from ... accessed data from the internal networks of major internet service ...
Cached Biology News:H. pylori vaccine shows promise in mouse studies 2Deepwater Horizon NRDA study shows possible oil impact on dolphins 2Deepwater Horizon NRDA study shows possible oil impact on dolphins 3Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats 2Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats 3Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats 4
...
Rat polyclonal to Vitamin B3 ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule, Vitamin B3 conjugated to BSA....
Request Info...
Amyloid stain....
Biology Products: